You are here

Industry Trends

Researchers find opioid-agonist treatment saves lives and money compared with detox
Four in 10 U.S. cases and deaths are linked to risk factors we can change
Under guidelines, nearly half of U.S. population will be diagnosed with hypertension
The less-expensive biosimilar will cut into J&J’s nearly $5 billion annual sales of infliximab
National Safety Council to launch education campaign
A random set of patients could “test” drugs nearing an OK
Tighter prescribing, drug courts also recommended
One in 10 naloxone-rescued OD patients die within a year
New grant will allow ICER to evaluate all newly approved U.S. medicines
Forty-six states allege drug manufacturers restrained competition
Insurer enlists CVS Health to help in replacing Express Scripts
Announcement follows judge’s ruling to toss patents
Reports indicate he worked to weaken federal efforts to restrict opioids
Sophisticated management of life-threatening complications could double cost of care